MaaT Pharma SA Sustainability Reports

MaaT Pharma S.A. is a clinical-stage biotechnology company focused on developing microbiome-driven therapies to restore gut microbiota symbiosis and improve clinical outcomes for cancer patients.

Sector: Professional & technical services

Country: France

Exchange: Euronext Paris

LEI: 969500CQQB6XUNW6CN97

FIGI: BBG00RMZCCQ0

10 reports from 2021 to 2025

• MaaT Pharma SA 2025 Universal Registration Document
• MaaT Pharma SA 2025 CSR Report
• MaaT Pharma SA 2025 Auditor's Report on the Annual Financial Statements
• MaaT Pharma SA 2024 Universal Registration Document
• MaaT Pharma SA 2023 Universal Registration Document